Accelerating global access to life-saving vaccines.

We apply rigorous science to build knowledge and support for the value of vaccines.

Updates
Webinar Recording: Avoiding Barriers to Access for a COVID-19 Vaccine
August 2020

The International Vaccine Access Center (IVAC) hosted a webinar on September 16th, “Avoiding Barriers to Access for a COVID-19 Vaccine.” Description: Even before the COVID-19 pandemic, countries worked to overcome a myriad of challenges when introducing new safe and effective vaccines. While policy makers and health advocates addressed barriers, from understanding disease burden and cost […]

Read More >
Visualizing Vaccines
August 2020

By Graphicacy Originally published on Medium OVERVIEW In 2016, the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health introduced its revolutionary online platform, VIEW-hub, as a one-stop resource for global vaccine data. This interactive, map-based platform allowed researchers, policymakers, public health officials, and program funders to call up data […]

Read More >
DoVE Return on Investment (ROI) Publication Launch
August 2020

The Decade of Vaccine Economics (DoVE) Project, carried out by the Johns Hopkins Bloomberg School of Public Health’s International Vaccine Access Center (IVAC) for nearly ten years, has computed the return-on-investment for vaccines preventing 10 infectious diseases in 73 countries that have received support from Gavi, the Vaccine Alliance.

Read More >
Digital Tools

IVAC’s digital platforms contain downloadable vaccine introduction maps, messaging compendiums, advocacy guides, and more.

Where We Work

IVAC works with governments and major research institutions in 38 countries

[Where We Work - Map]